TMAO levels are elevated in T2D and predictive of future diabetes [60], and markedly suppressing its formation through genetic or pharmacological inhibition of the hepatic FMO3 enzyme has been proposed to improve insulin secretion and glycemic control in diabetic mice [59]. The gene discussed is INS; the disease is type 2 diabetes mellitus.